Welcome to The Morning CheckUp, ThinkProgress Health’s 7:00 AM round-up of the latest in health policy and politics. Here is what we’re reading, what are you?
Planned Parenthood funding is the new litmus test: “Abortion rights opponents describe Planned Parenthood’s public funding as a new ‘litmus test’ for Republican candidates — and an easy way to draw a distinction with President Barack Obama — while abortion rights supporters are eagerly eyeing the debate as an attack on contraceptives that could mobilize the Democratic base.” [Politico]
Health reform’s day in court: The 11th circuit judges gave the law mixed reviews, “but the actual substance of those questions – and some side comments that the judges made – suggested they were ready to reject essential pieces of the legal challenge.” [Jonathan Cohn[
Lifting the ban against abortion services on military bases: Sen. Kirsten Gillibrand (D-NY) and Rep. Louise Slaughter (D-NY) recently introduced legislation that would “allow servicewomen to use private funds to obtain abortion care at military health facilities and lift the ban that denies U.S. servicewomen and dependents insurance coverage for abortion services in cases of rape or incest. [RH Reality Check]
North Carolina House approves waiting period for abortion: lawmakers in the House “voted 71-48 to approve the Women’s Right to Know Act, which requires women to get specialized counseling and wait 24 hours before having an abortion.” [Citizen Times]
Iowa House bans abortions after 18 weeks: “The Iowa House of Representatives passed a bill Wednesday that would establish the toughest abortion restriction in the country, banning the procedure after 18 weeks.” [Reuters]
Bipartisan group of lawmakers say NIH funding is key to curbing health costs: “A bipartisan group of Senate and House lawmakers are urging the chairs and ranking members of their respective chambers’ appropriations subcommittees to support funding for the National Institutes of Health, which they say is essential to keeping the country competitive in biomedical research and offers one of the best hopes in helping contain the increasing costs of health care.” [Inside Health Policy]